XML 13 R2.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($)
shares in Millions, $ in Millions
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Income Statement [Abstract]    
Net operating revenues $ 1,124.0 $ 1,046.0
Operating expenses:    
Salaries and benefits 620.8 570.2
Other operating expenses 150.1 141.2
Occupancy costs 19.6 18.6
Supplies 40.1 39.9
General and administrative expenses 53.4 61.1
Depreciation and amortization 52.5 45.9
Total operating expenses 936.5 876.9
Interest expense and amortization of debt discounts and fees 37.2 35.6
Other (income) loss (3.7) 0.1
Equity in net income of nonconsolidated affiliates (2.5) (2.3)
Income from continuing operations before income tax expense 156.5 135.7
Provision for income tax expense 30.8 30.0
Income from continuing operations 125.7 105.7
Loss from discontinued operations, net of tax (0.5) (0.5)
Net and comprehensive income 125.2 105.2
Less: Net and comprehensive income attributable to noncontrolling interests (22.9) (21.4)
Net and comprehensive income attributable to Encompass Health $ 102.3 $ 83.8
Weighted average common shares outstanding:    
Basic (shares) 98.4 97.8
Diluted (shares) 99.7 99.4
Basic earnings per share attributable to Encompass Health common shareholders:    
Continuing operations (in dollars per share) $ 1.05 $ 0.86
Discontinued operations (in dollars per share) (0.01) (0.01)
Net Income (in dollars per share) 1.04 0.85
Diluted earnings per share attributable to Encompass Health common shareholders:    
Continuing operations (in dollars per share) 1.04 0.85
Discontinued operations (in dollars per share) (0.01) (0.01)
Net income (in dollars per share) $ 1.03 $ 0.84
Amounts attributable to Encompass Health common shareholders:    
Income from continuing operations $ 102.8 $ 84.3
Loss from discontinued operations, net of tax (0.5) (0.5)
Net and comprehensive income attributable to Encompass Health $ 102.3 $ 83.8